Clinical Trial Update: A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors [Phase 2]

View source ↗

Summary

A Phase 2 prospective trial evaluating cabazitaxel in patients with non-seminomatous germ cell tumors; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-seminomatous Germ Cell Tumors

Drugs mentioned

• Cabazitaxel (cabazitaxel)
• Jevtana (cabazitaxel)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Non-seminomatous Germ-cell Tumors | Phase 2 | Status: COMPLETED